MATTHEW REED, MD
Ophthalmology Physician · NEWPORT NEWS, VA
Individual Active NPI 1790753564
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,524 | 118,053 | $14,694,231 | $6,198,194 | $4,873,429 |
| 2023 | 1,556 | 64,829 | $12,885,940 | $5,932,515 | $4,669,471 |
| 2022 | 1,560 | 28,884 | $11,715,035 | $5,611,299 | $4,412,244 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 105,660 | $34 | $27 |
| 92134 | Imaging of retina | 2,793 | $39 | $29 |
| 67028 | Injection of drug into eye | 2,545 | $120 | $92 |
| J0178 | Injection, aflibercept, 1 mg | 1,768 | $829 | $652 |
| 92014 | Established patient complete exam of visual system | 1,443 | $123 | $86 |
| J2778 | Injection, ranibizumab, 0.1 mg | 995 | $161 | $123 |
| 92250 | Photography of the retina | 544 | $36 | $27 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 449 | $89 | $61 |
| J0177 | Injection, aflibercept hd, 1 mg | 320 | $317 | $254 |
| J9035 | Injection, bevacizumab, 10 mg | 45 | $71 | $51 |
| 67228 | Destruction of leaking blood vessels of retina using laser | 24 | $301 | $226 |
| 67210 | Destruction of growth of retina using a laser | 18 | $504 | $404 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 0101239364 | VA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Virginia
- NPI 1003893694
- NPI 1235134214
- NPI 1629212683
- NPI 1407841133
- NPI 1720065394
- NPI 1437136009
- NPI 1851364772
- NPI 1093701682
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.